The pharmaceutical industry helped build factory farming. Now it’s muddying the debate over meat’s carbon footprint.

Elanco Animal Health (NYSE:ELAN – Free Report) had its target price cut by UBS Group from $18.00 to $17.00 in a research note released on Wednesday morning,Benzinga reports. They currently have a buy ...

Elanco Animal Health (NYSE:ELAN – Free Report) had its target price trimmed by Barclays from $20.00 to $19.00 in a research report released on Wednesday morning,Benzinga reports. The firm currently ...

Zoetis also has an H5N1 vaccine, for which it received a conditional license in 2016 and a contract award for the USDA’s ...

Elanco has struck an agreement to distribute a vaccine that may protect cattle for up to 12 months against bird flu ...

The global veterinary dermatology market, valued at US$18.59 billion in 2024, is forecasted to grow at a robust CAGR of 8.5%, reaching US$20.11 ...

We recently compiled a list of the 12 Best Low Price Pharma Stocks To Invest In Right Now. In this article, we are going to ...

Highlights,Elanco Animal Health reported a miss in earnings, with EPS falling short of expectations.,Analysts adjusted their ...

In a big win for House Speaker Mike Johnson, House Republicans got their budget plan through the chamber on a 217-215 vote.

Elanco Animal Health Incorporated has entered into an agreement with South Dakota-based Medgene to leverage the company's ...

Elanco Animal Health Incorporated (NYSE: ELAN) today announced it has entered into an agreement with South Dakota-based Medgene to leverage the company’s innovative vaccine platform technology.